Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Debt (2016 - 2025)

Historic Total Debt for Mimedx (MDXG) over the last 11 years, with Q3 2025 value amounting to $18.2 million.

  • Mimedx's Total Debt fell 1275.98% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year decrease of 1275.98%. This contributed to the annual value of $18.8 million for FY2024, which is 6164.89% down from last year.
  • Per Mimedx's latest filing, its Total Debt stood at $18.2 million for Q3 2025, which was down 1275.98% from $18.5 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Total Debt registered a high of $49.1 million during Q4 2023, and its lowest value of $18.2 million during Q3 2025.
  • For the 5-year period, Mimedx's Total Debt averaged around $37.7 million, with its median value being $48.0 million (2021).
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 103.92% in 2023, then tumbled by 6164.89% in 2024.
  • Quarter analysis of 5 years shows Mimedx's Total Debt stood at $48.1 million in 2021, then increased by 0.97% to $48.6 million in 2022, then increased by 1.04% to $49.1 million in 2023, then plummeted by 61.65% to $18.8 million in 2024, then dropped by 3.27% to $18.2 million in 2025.
  • Its Total Debt was $18.2 million in Q3 2025, compared to $18.5 million in Q2 2025 and $18.7 million in Q1 2025.